Related Experiment Video
Updated: May 16, 2025
08:47
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
9.6K
CDC42 Regulatory Patterns Related To Inflammatory Bowel Disease and Hyperglycemia
Marija Stojanovic1,2, Devendra K Agrawal1
1Department of Translational Research, Western University of Health Sciences, Pomona, California 91766, USA.
Journal of Bioinformatics and Systems Biology : Open Access
|April 4, 2025
Summary
Cdc42, a key regulator of cell functions, is implicated in inflammatory bowel disease (IBD) and hyperglycemia. Bioinformatics analysis predicted gene interactions, suggesting potential therapeutic targets for managing IBD in diabetic conditions.
Area of Science:
- Molecular Biology
- Cell Biology
- Bioinformatics
Background:
- Cdc42 is a Rho GTPase regulating fundamental cellular processes like cytoskeleton dynamics and cell polarity.
- Cdc42 plays roles in gastrointestinal epithelial barrier function and insulin secretion.
- Evidence suggests Cdc42 signaling in inflammatory bowel disease (IBD) and hyperglycemia (diabetes mellitus).
Purpose of the Study:
- To investigate the role of Cdc42 signaling in the pathophysiology of inflammatory bowel disease under hyperglycemic conditions.
- To predict transcriptional factor-gene interactions related to Cdc42 signaling in IBD and hyperglycemia using bioinformatics analysis.
Main Methods:
- Bioinformatics analysis was employed to predict transcriptional factor-gene interactions.
- In silico analysis identified key molecules influencing Cdc42-related gene expression.
Main Results:
- The study predicted various interactions between genes and transcriptional factors involved in Cdc42 signaling.
- In silico analysis revealed molecules with significant predicted effects on specific genes within the context of IBD and hyperglycemia.
Conclusions:
- Understanding Cdc42's molecular pathway in IBD and hyperglycemia is crucial.
- Predicted interactions highlight potential therapeutic targets for disease management and control.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
134
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
134
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
259
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
259
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
99
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
99
01:17Chronic Bowel Disorders: Introduction
345
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
345
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
103
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
103
01:20The JAK-STAT Signaling Pathway
8.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.5K